Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TEMSIROLIMUS, with a corresponding US DMF Number 26825.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 01, 2013, and payment made on March 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II